Astrana Health, Inc.
ASTH
$29.56
-$1.82-5.80%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -143.19% | -16.05% | 29.23% | 20.06% | -43.99% |
Total Depreciation and Amortization | 11.87% | -2.38% | 46.02% | 3.96% | 13.87% |
Total Amortization of Deferred Charges | -0.66% | -0.44% | 0.22% | 30.86% | 47.68% |
Total Other Non-Cash Items | 108.27% | -10.23% | 3.68% | 158.64% | -194.06% |
Change in Net Operating Assets | -1,557.55% | 115.64% | 44.08% | -239.44% | 161.39% |
Cash from Operations | -132.22% | 46.55% | 287.95% | -69.03% | 25.28% |
Capital Expenditure | -10.28% | 19.08% | -668.56% | 94.77% | -71.91% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -3,284.60% | 98.58% | -26.23% | -2,655.66% | 63.42% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 99.45% | 62.72% | 34.30% | -690.72% | 90.17% |
Cash from Investing | -311.05% | 89.86% | -12.51% | -521.68% | 67.23% |
Total Debt Issued | -100.00% | -97.42% | -45.16% | -60.91% | 19,785.37% |
Total Debt Repaid | -216.88% | 48.95% | -108.83% | 98.20% | -58,130.77% |
Issuance of Common Stock | 3.98% | -- | -- | -- | -- |
Repurchase of Common Stock | 18.14% | 69.08% | -- | -- | -235.33% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -2,539.36% |
Other Financing Activities | -1,026.15% | 87.90% | -6,103.33% | 100.61% | -688.60% |
Cash from Financing | -378.59% | -106.75% | -55.57% | 786.78% | 2,451.57% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -362.47% | 339.16% | -122.97% | 107.84% | 199.43% |